Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 18, 2024 07:30 ET
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it...
Apr 18, 2024 07:30 ET
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”)...
Apr 18, 2024 07:30 ET
Bombardier to Report First Quarter Financial Results and Hold Annual General Meeting of Shareholders on April 25, 2024
Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2024 on April 25, 2024. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual format. Financial results for the...
Apr 18, 2024 07:30 ET
Daniel Bono Joins Two Six Technologies as SVP of Intelligence Solutions
Two Six Technologies (Two Six), a high-growth, technology-focused provider of products and expertise to U.S. national security customers, announced it has appointed Dan Bono as Senior Vice President of Intelligence Solutions. With a longstanding...
Apr 18, 2024 07:30 ET
First Generation of Advance Silicon-Based Anode Material Continues Delivering Strong Performance
HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce continued milestones achieved by its France-based...
Apr 18, 2024 07:30 ET
NevGold Announces Positive Copper Porphyry Potential at the Zeus Copper Project in the Hercules Copper Trend, Idaho
NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has identified significant copper porphyry potential after completing a geological review and 3-D model of the newly staked Zeus...
Apr 18, 2024 07:30 ET
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and...
Apr 18, 2024 07:30 ET
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMI
Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing innovative medical therapies that create positive patient stories in the hospital, community and public health settings, today announced that three new pre-clinical...
Apr 18, 2024 07:30 ET
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024...
Apr 18, 2024 07:23 ET
Transocean Ltd. Announces Results of Tender Offers
Transocean Ltd. (NYSE: RIG) announced today on behalf of Transocean Inc., its wholly-owned subsidiary (the “Company” and, together with Transocean Ltd., “Transocean”), the results of the Company’s previously announced tender offers to purchase for...
Apr 18, 2024 07:15 ET
JD.com Files Its Annual Report on Form 20-F
JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it filed its annual report on Form 20-F for the fiscal...
Apr 18, 2024 07:05 ET
The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results
The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close....
Apr 18, 2024 07:00 ET
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024
Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for March 2024. Rahul Mewawalla, CEO and President, commented, “We are very...
Apr 18, 2024 07:00 ET
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024...
Apr 18, 2024 07:00 ET
A category innovation: Pure Sunfarms introduces Hi-Def Pre-Rolls
Pure Sunfarms Corp. (“Pure Sunfarms”), a leading producer in the Canadian cannabis market and wholly owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF), introduces the next product in the evolution of cannabis, Hi-Def Pre-Rolls....
Apr 18, 2024 07:00 ET
Aesthetic Medical International to Announce FY2023 Annual Report on April 25, 2024
Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its annual report for the fiscal year of 2023 after the...
Apr 18, 2024 07:00 ET
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, May 2, 2024, at 8:00 a.m. ET...
Apr 18, 2024 07:00 ET
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
Anaqua, the leading provider of innovation and intellectual property (IP) management technology for corporations, law firms and governments, announces advancements in its Foreign Filing offering, enhancing the capabilities of its IP management...
Apr 18, 2024 07:00 ET
Bacchus Capital Engaged as Strategic & Project Funding Adviser
Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to announce that it has engaged Bacchus Capital Advisers Limited (Bacchus) as its strategic and project funding adviser in relation to the Kharmagtai Copper-Gold Project...